Trials / Conditions / ER+/HER2- Breast Cancer
ER+/HER2- Breast Cancer
3 registered clinical trials studyying ER+/HER2- Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer NCT07109284 | West China Hospital | Phase 2 |
| Recruiting | Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemother NCT06964906 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Recruiting | A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. NCT06064812 | Forward Pharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |